Specify a stock or a cryptocurrency in the search bar to get a summary
Impedimed Ltd
IPDImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California. Address: 5900 Pasteur Ct., Carlsbad, CA, United States, 92008
Analytics
WallStreet Target Price
0.22 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures IPD
Dividend Analytics IPD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IPD
Stock Valuation IPD
Financials IPD
Results | 2019 | Dynamics |